Search

everythinglearnresearchcommunity

for

Search:↓

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Certain natural compounds called terpenes may help prevent prostate cancer.

Epipharyngeal Abrasive Therapy helps reduce symptoms in Long COVID patients with chronic epipharyngitis.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Balding might help identify men at higher risk for severe COVID-19, but more research is needed.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

COVID-19 can cause hair loss, but specialists can help treat it.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Social media data can help track and predict COVID-19 symptoms and trends.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Testosterone's effects on COVID-19 are unclear and need more research.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.